Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum.

Background. Artemisinin-based combination therapy (ACT) reduces microscopically confirmed gametocytemia and mosquito infection. However, molecular techniques have recently revealed high prevalences of submicroscopic gametocytemia. Our objective here was to determine the effect of sulfadoxine-pyrimethamine (SP) monotherapy and treatment with SP plus amodiaquine (AQ), SP plus artesunate (AS), and artemether-lumefantrine (AL; Coartem) on submicroscopic gametocytemia and infectiousness.Methods. Kenyan children (n=528) 6 months-10 years of age were randomized to 4 treatment arms. Gametocytemia was determined by both microscopy and Pfs25 RNA-based quantitative nucleic acid sequence-based amplification (Pfs25 QT-NASBA). Transmission was determined by membrane-feeding assays.Results. Gametocyte prevalence, as determined by Pfs25 QT-NASBA, was 89.4% (219/245) at enrollment and decreased after treatment with SP plus AS, SP plus AQ, and AL. Membrane-feeding assays for a group of randomly selected children revealed that the proportion of infectious children was as much as 4-fold higher than expected when based on microscopy. ACT did not significantly reduce the proportion of infectious children but did reduce the proportion of infected mosquitoes.Conclusions. Submicroscopic gametocytemia is common after treatment and contributes considerably to mosquito infection. Our findings should be interpreted in the context of transmission intensity, but the effect of ACT on malaria transmission appears to be moderate and restricted to the duration of gametocyte carriage and the proportion of mosquitoes that are infected by carriers.

[1]  T. Bousema,et al.  (Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate. , 2006, International journal for parasitology.

[2]  R. Sauerwein,et al.  A randomized, placebo‐controlled, double‐blind trial on sulfadoxine–pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria , 2005, Tropical medicine & international health : TM & IH.

[3]  R. Hallett,et al.  Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial , 2005, The Lancet.

[4]  F. Checchi,et al.  Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial , 2005, The Lancet.

[5]  C. Drakeley,et al.  Reduction of Malaria Transmission to Anopheles Mosquitoes with a Six-Dose Regimen of Co-Artemether , 2005, PLoS medicine.

[6]  Petra Schneider,et al.  Real-Time Nucleic Acid Sequence-Based Amplification Is More Convenient than Real-Time PCR for Quantification of Plasmodium falciparum , 2005, Journal of Clinical Microbiology.

[7]  H. Ferguson,et al.  Impact of genetic complexity on longevity and gametocytogenesis of Plasmodium falciparum during the dry and transmission-free season of eastern Sudan. , 2005, International journal for parasitology.

[8]  J. Koella,et al.  Host genotype by parasite genotype interactions underlying the resistance of anopheline mosquitoes to Plasmodium falciparum , 2005, Malaria Journal.

[9]  Grant Dorsey,et al.  Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial , 2004, The Lancet.

[10]  R. Hallett,et al.  Combination Therapy Counteracts the Enhanced Transmission of Drug-Resistant Malaria Parasites to Mosquitoes , 2004, Antimicrobial Agents and Chemotherapy.

[11]  Petra Schneider,et al.  Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification. , 2004, Molecular and biochemical parasitology.

[12]  Ian M Hastings,et al.  Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. , 2004, The American journal of tropical medicine and hygiene.

[13]  J. Sattabongkot,et al.  Infectivity of Asymptomatic Plasmodium-Infected Human Populations to Anopheles dirus Mosquitoes in Western Thailand , 2004, Journal of medical entomology.

[14]  M. Galinski,et al.  WHO, the Global Fund, and medical malpractice in malaria treatment , 2004, The Lancet.

[15]  P Garner,et al.  Artesunate combinations for treatment of malaria: meta-analysis , 2004, The Lancet.

[16]  C. Drakeley,et al.  Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short‐lived reduction in infectiousness for mosquitoes , 2004, Tropical medicine & international health : TM & IH.

[17]  G. Killeen,et al.  Comparative field evaluation of the Mbita trap, the Centers for Disease Control light trap, and the human landing catch for sampling of malaria vectors in western Kenya. , 2004, The American journal of tropical medicine and hygiene.

[18]  Nirbhay Kumar,et al.  Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu onPlasmodium falciparum , 2004, Parasitology Research.

[19]  P. Olliaro,et al.  Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double-blind, placebo-controlled trial. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[20]  P. Olliaro,et al.  Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[21]  A. Hubbard,et al.  Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. , 2003, The American journal of tropical medicine and hygiene.

[22]  P. Rosenthal,et al.  Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial , 2002, The Lancet.

[23]  H. Babiker,et al.  Dynamics of gametocytes among Plasmodium falciparum clones in natural infections in an area of highly seasonal transmission. , 2002, The Journal of infectious diseases.

[24]  C. Drakeley,et al.  Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. , 2001, The Journal of infectious diseases.

[25]  L. Seidlein,et al.  Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria , 2001, Tropical medicine & international health : TM & IH.

[26]  U. d’Alessandro,et al.  Modelling a predictable disaster: the rise and spread of drug-resistantmalaria. , 2000, Parasitology today.

[27]  Richard N. Price,et al.  Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study , 2000, The Lancet.

[28]  P. Olliaro,et al.  Averting a malaria disaster , 1999, The Lancet.

[29]  J. Verhave,et al.  Detection of Plasmodium falciparum gametocytes with the OBC test and Giemsa-stained thick blood films for malaria transmission studies in Cameroon. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[30]  C. Mendis,et al.  The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector. , 1998, The American journal of tropical medicine and hygiene.

[31]  Mutero Cm,et al.  Malaria prevalence and use of self-protection measures against mosquitoes in Suba District, Kenya. , 1998 .

[32]  C. Mutero,et al.  Malaria prevalence and use of self-protection measures against mosquitoes in Suba District, Kenya. , 1998, East African medical journal.

[33]  A. Read,et al.  Why so few transmission stages? Reproductive restraint by malaria parasites. , 1997, Parasitology today.

[34]  R. Price,et al.  Effects of artemisinin derivatives on malaria transmissibility , 1996, The Lancet.

[35]  P. Ambroise‐Thomas,et al.  High human malarial infectivity to laboratory-bred Anopheles gambiae in a village in Burkina Faso. , 1993, The American journal of tropical medicine and hygiene.

[36]  M. Salimans,et al.  Rapid and simple method for purification of nucleic acids , 1990, Journal of clinical microbiology.

[37]  R. Sinden.  The cell biology of sexual development in Plasmodium , 1983, Parasitology.

[38]  J. Meuwissen,et al.  Cultivation of fertile Plasmodium falciparum gametocytes in semi-automated systems. 1. Static cultures. , 1982, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[39]  L. Molineaux,et al.  The Garki project: Research on the epidemiology and control of malaria in the Sudan savanna of West Africa , 1980 .

[40]  Colbourne Mj.  The effect of prolonged examination of bloodfilms on the parasite rate. , 1956 .

[41]  M. Colbourne.  The effect of prolonged examination of bloodfilms on the parasite rate. , 1956, The West African medical journal.

[42]  Geneva,et al.  ANTIMALARIAL DRUG COMBINATION THERAPY Report of a WHO Technical Consultation , 2022 .